- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ILMN
Recent news which mentions ILMN
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
From Benzinga
Why Jim Cramer Likes Illumina And Enterprise Products Partners
January 06, 2022
From Benzinga
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
January 06, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 03, 2022
From Benzinga
Why Jim Cramer Likes Illumina, SoFi And More
December 08, 2021
From Benzinga
Bionano Genomics Proves Not Everything Genetic is Gold
December 01, 2021
From InvestorPlace
10x Genomics Stock: Bull vs. Bear
November 24, 2021
From Motley Fool
Wait for Bionano Stock to Fall Further Before Buying
November 23, 2021
From InvestorPlace
Following Rough Year, Is Burning Rock Set To Turn The Corner?
November 18, 2021
From Benzinga
Europe To Layout Objections to Illumina-Grail Deal: Bloomberg
November 16, 2021
Tickers
ILMN
From Benzinga
Illumina Clocks 40% Growth In Q3; Earnings Beat Expectations
November 05, 2021
Tickers
ILMN
From Benzinga
Illumina, inc (ILMN) Q3 2021 Earnings Call Transcript
November 04, 2021
Tickers
ILMN
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
From Benzinga
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
From Motley Fool
More than a quarter of Nasdaq-100 stocks are in bear markets — Wall Street sees a buying opportunity
September 29, 2021
From MarketWatch
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
September 28, 2021
From Motley Fool
The 1 Stock I'd Buy Right Now
September 18, 2021
From Motley Fool
3 Crash-Ready Stocks to Buy in September
September 14, 2021
From Motley Fool
UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types
September 13, 2021
Tickers
ILMN
From Benzinga
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
September 07, 2021
From Benzinga
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
From InvestorPlace
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
From InvestorPlace
Workday And Lam Research Lead The QQQ
August 27, 2021
From Benzinga
7 Great Growth Stocks to Buy Now to Build Your Portfolio
August 24, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.